{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:48:41Z","timestamp":1787021321790,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["T32 DE 7327"],"award-info":[{"award-number":["T32 DE 7327"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"NIDCR","doi-asserted-by":"publisher","award":["DE-018499"],"award-info":[{"award-number":["DE-018499"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"NIDCR","doi-asserted-by":"publisher","award":["DE-019917"],"award-info":[{"award-number":["DE-019917"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.bbrc.2016.10.012","type":"journal-article","created":{"date-parts":[[2016,10,9]],"date-time":"2016-10-09T14:10:55Z","timestamp":1476022255000},"page":"42-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Possible pathogenic engagement of soluble Semaphorin 4D produced by \u03b3\u03b4T cells in medication-related osteonecrosis of the jaw (MRONJ)"],"prefix":"10.1016","volume":"480","author":[{"given":"Alexandru","family":"Movila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7175-6815","authenticated-orcid":false,"given":"Hani","family":"Mawardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Kiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Egashira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sook-Bin","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihisa","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2016.10.012_bib1","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20132014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J.\u00a0Oral Maxillofac. Surg."},{"key":"10.1016\/j.bbrc.2016.10.012_bib2","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bone.2007.04.196","article-title":"Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?","volume":"41","author":"Reid","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bbrc.2016.10.012_bib3","first-page":"3111","article-title":"Bisphosphonates and oral cavity avascular bone necrosis: a review of twelve cases","volume":"26","author":"Salesi","year":"2006","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbrc.2016.10.012_bib4","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1177\/0022034511420430","article-title":"A\u00a0role of oral bacteria in bisphosphonate-induced osteonecrosis of the jaw","volume":"90","author":"Mawardi","year":"2011","journal-title":"J.\u00a0Dent. Res."},{"key":"10.1016\/j.bbrc.2016.10.012_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nri1003","article-title":"Semaphorins in interactions between T cells and antigen-presenting cells","volume":"3","author":"Kikutani","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2016.10.012_bib6","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/nm.2489","article-title":"Suppression of bone formation by osteoclastic expression of semaphorin 4D","volume":"17","author":"Negishi-Koga","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2016.10.012_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/intimm\/7.1.1","article-title":"Activation signals are delivered through two distinct epitopes of CD100, a unique 150 kDa human lymphocyte surface structure previously defined by BB18 mAb","volume":"7","author":"Herold","year":"1995","journal-title":"Int. Immunol."},{"key":"10.1016\/j.bbrc.2016.10.012_bib8","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1073\/pnas.0606344104","article-title":"Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury","volume":"104","author":"Zhu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2016.10.012_bib9","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/intimm\/dxg098","article-title":"Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: implications for the regulation of immune and inflammatory responses","volume":"15","author":"Ishida","year":"2003","journal-title":"Int. Immunol."},{"key":"10.1016\/j.bbrc.2016.10.012_bib10","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.molimm.2013.05.228","article-title":"Neuroimmune semaphorin 4D is necessary for optimal lung allergic inflammation","volume":"56","author":"Shanks","year":"2013","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbrc.2016.10.012_bib11","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.4049\/jimmunol.177.5.3406","article-title":"CD100 enhances dendritic cell and CD4+ cell activation leading to pathogenetic humoral responses and immune complex glomerulonephritis","volume":"177","author":"Li","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2016.10.012_bib12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.clim.2015.12.012","article-title":"Soluble SEMA4D\/CD100: a novel immunoregulator in infectious and inflammatory diseases","volume":"163","author":"Maleki","year":"2016","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.bbrc.2016.10.012_bib13","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.nbd.2014.10.008","article-title":"SEMA4D compromises blood-brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease","volume":"73","author":"Smith","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2016.10.012_bib14","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/art.39086","article-title":"Semaphorin 4D contributes to rheumatoid arthritis by inducing inflammatory cytokine production: pathogenic and therapeutic implications","volume":"67","author":"Yoshida","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bbrc.2016.10.012_bib15","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.bbrc.2016.10.012_bib16","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1074\/jbc.M609570200","article-title":"MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D","volume":"282","author":"Basile","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2016.10.012_bib17","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1182\/blood.V97.11.3498","article-title":"Functional soluble CD100\/Sema4D released from activated lymphocytes: possible role in normal and pathologic immune responses","volume":"97","author":"Wang","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2016.10.012_bib18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-065X.1997.tb01008.x","article-title":"Alpha beta and gamma delta T-cell networks and their roles in natural resistance to viral infections","volume":"159","author":"Welsh","year":"1997","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbrc.2016.10.012_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-4419-1050-9_2","article-title":"Activation of gammadelta T cells by bisphosphonates","volume":"658","author":"Thompson","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbrc.2016.10.012_bib20","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/jbmr.1769","article-title":"Can peripheral blood gammadelta T cells predict osteonecrosis of the jaw? an immunological perspective on the adverse drug effects of aminobisphosphonate therapy","volume":"28","author":"Kalyan","year":"2013","journal-title":"J.\u00a0Bone Min. Res."},{"key":"10.1016\/j.bbrc.2016.10.012_bib21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1399-302X.2007.00348.x","article-title":"Cross-reactive adaptive immune response to oral commensal bacteria results in an induction of receptor activator of nuclear factor-kappaB ligand (RANKL)-dependent periodontal bone resorption in a mouse model","volume":"22","author":"Kawai","year":"2007","journal-title":"Oral Microbiol. Immunol."},{"key":"10.1016\/j.bbrc.2016.10.012_bib22","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.4049\/jimmunol.166.7.4341","article-title":"Biological activity of soluble CD100. I. The extracellular region of CD100 is released from the surface of T lymphocytes by regulated proteolysis","volume":"166","author":"Elhabazi","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2016.10.012_bib23","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/jbmr.2854","article-title":"Macrophage migration inhibitory factor (MIF) supports homing of osteoclast precursors to peripheral osteolytic lesions","volume":"31","author":"Movila","year":"2016","journal-title":"J.\u00a0Bone Min. Res."},{"issue":"Suppl.\u00a02","key":"10.1016\/j.bbrc.2016.10.012_bib24","doi-asserted-by":"crossref","first-page":"e679","DOI":"10.1111\/cid.12307","article-title":"Jaw bone samples from bisphosphonate-treated patients: a pilot cohort study","volume":"17","author":"Cardemil","year":"2015","journal-title":"Clin. Implant Dent. Relat. Res."},{"key":"10.1016\/j.bbrc.2016.10.012_bib25","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1158\/1078-0432.CCR-13-0042","article-title":"IL-17-mediated M1\/M2 macrophage alteration contributes to pathogenesis of bisphosphonate-related osteonecrosis of the jaws","volume":"19","author":"Zhang","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2016.10.012_bib26","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.immuni.2012.05.026","article-title":"The CD100 receptor interacts with its plexin B2 ligand to regulate epidermal gammadelta T cell function","volume":"37","author":"Witherden","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.bbrc.2016.10.012_bib27","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/mi.2013.32","article-title":"Protection against colitis by CD100-dependent modulation of intraepithelial gammadelta T lymphocyte function","volume":"7","author":"Meehan","year":"2014","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.bbrc.2016.10.012_bib28","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.2147\/OTT.S88463","article-title":"Bioinformatics analyses of differentially expressed genes associated with bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma","volume":"8","author":"Sun","year":"2015","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.bbrc.2016.10.012_bib29","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/odi.12513","article-title":"Immune cellular profile of bisphosphonate-related osteonecrosis of the jaw","volume":"22","author":"de Barros Silva","year":"2016","journal-title":"Oral Dis."},{"key":"10.1016\/j.bbrc.2016.10.012_bib30","first-page":"528","article-title":"Experimental studies on the pathogenesis of acute respiratory distress syndrome","volume":"98","author":"Cai","year":"1985","journal-title":"Chin. Med. J. Engl."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X16316679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X16316679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T16:23:34Z","timestamp":1536337414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X16316679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0006291X16316679"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.10.012","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Possible pathogenic engagement of soluble Semaphorin 4D produced by \u03b3\u03b4T cells in medication-related osteonecrosis of the jaw (MRONJ)","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}